recombinant MVA vector vaccine (German Center for Infection Research)

N/A

Report date: 2025/01/26 17:44:05

Base Information

Drug Namerecombinant MVA vector vaccine (German Center for Infection Research)
Drug Alias NameSARS-CoV-2 vaccine (recombinant MVA vector) (German Center for Infection Research)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeutsches Zentrum für Infektionsforschung eV
China Registration ClassN/A

Develop Information

Active CompaniesDeutsches Zentrum für Infektionsforschung eV
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A